ambevsacvm358oct2015_6ka.htm - Generated by SEC Publisher for SEC Filing

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K/A

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

For the month of January, 2016

Commission File Number 1565025

AMBEV S.A.

(Exact name of registrant as specified in its charter)

AMBEV S.A.

(Translation of Registrant's name into English)

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___ Form 40-F _______

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes _______ No ___X____

CONSOLIDATED FORM

Management and Related Persons’ Transactions of Securities Issued by the Company

Article 11 - CVM Instruction # 358/2002

In October, 2015 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002⁽¹⁾:

Company Name: Ambev S.A.

Group and Related Persons

( )

Board of Directors

( X )

Management

( )

Fiscal Council

( )

Technical and Consulting Committees

Initial Balance

Securities / Derivatives

Securities Characteristics ⁽²⁾

Quantity

Same Class and Type

Total

Common

7,814,595

0.0497

ADR (*)

Common

552,830

0.0035

Transactions in the month

Securities / Derivatives

Securities Characteristics ⁽²⁾

Intermediary

Operation

Day

Quantity

Price R$

Volume (R$) ⁽³⁾

Common

Direct with the Company

Exerc Options

173,250

2.31648

401,330.16

Common

Direct with the Company

Exerc Options

121,500

4.14096

503,126.64

Common

Direct with the Company

Exerc Options

69,025

0.49852

34,410.34

Common

Direct with the Company

Exerc Options

42,100

0.92106

38,776.63

Common

Direct with the Company

Exerc Options

32,700

2.11284

69,089.87

Common

Direct with the Company

Exerc Options

144,375

2.31648

334,441.80

Common

Direct with the Company

Exerc Options

111,200

4.14096

460,474.75

Total Buy

694,150

1,841,650.19

Common

Direct with the Company

Sell

45,474

19.89

904,477.86

Common

Direct with the Company

Sell

47,360

19.79

937,254.40

Total Sell

92,834

1,841,732.26

Final Balance

Securities / Derivatives

Securities Characteristics ⁽²⁾

Quantity

Same Class and Type

Total

Common

8,415,911

0.0535

ADR (*)

Common

552,830

0.0035

(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) Quantity multiplied by price.

Note: These consolidated data must have information by group: Directors, Management (which have not been included in the Board of Directors), etc.

(*) Each ADR is equivalent to 1 (one) share.

CONSOLIDATED FORM

Management and Related Persons’ Transactions of Securities Issued by the Company

Article 11 - CVM Instruction # 358/2002

In October, 2015 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002⁽¹⁾:

Company Name: Ambev S.A.
Group and related persons	( X ) Board of Directors	( ) Management	( ) Fiscal Council		( ) Technical and Consulting Committees
Initial Balance
Securities / Derivatives	Securities Characteristics ⁽²⁾			Quantity		%
						Same Class and Type	Total
Shares	Common			25,213,286		0.1604	0.1604
ADR (*)	Common			16,285,039		0.1034	0.1034
Final Balance
Securities / Derivatives	Securities Characteristics ⁽²⁾			Quantity		%
						Same Class and Type	Total
Shares	Common			25,213,286		0.1604	0.1604
ADR (*)	Common			16,285,039		0.1034	0.1034

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) Quantity multiplied by price.

Note: These consolidated data must have information by group: Directors, Management (which have not been included in the Board of Directors), etc.

(*) Each ADR is equivalent to 1 (one) share.

Note: Form resubmitted in January 15, 2016 with the exclusion, only on the Board of Directors table, of the shares and ADRs held by the controlling shareholders of the Company (Ambrew S.A., Interbrew International B.V. and Fundação Antonio e Helena Zerrenner INB). For more information about the participation of our controlling shareholders, please see our Reference Form or 20-F.

CONSOLIDATED FORM

Management and Related Persons’ Transactions of Securities Issued by the Company

Article 11 - CVM Instruction # 358/2002

In October, 2015 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002⁽¹⁾:

Company Name: Ambev S.A.
Group and related persons	( ) Board of Directors	( ) Management	(X) Fiscal Council		( ) Technical and Consulting Committees
Initial Balance
Securities / Derivatives	Securities Characteristics ⁽²⁾			Quantity		%
						Same Class and Type	Total
Shares	Common			7,225		0.0000	0.0000
Final Balance
Securities / Derivatives	Securities Characteristics ⁽²⁾			Quantity		%
						Same Class and Type	Total
Shares	Common			7,225		0.0000	0.0000

(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) Quantity multiplied by price.

Note: These consolidated data must have information by group: Directors, Management (which have not been included in the Board of Directors), etc.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: January 15, 2016


	AMBEV S.A.

	By:	/s/ Ricardo Rittes de Oliveira Silva
		Ricardo Rittes de Oliveira Silva Chief Financial and Investor Relations Officer